LSE:SYNT 1 Year Share Price vs Fair Value
Explore Synthomer’s Fair Values from the Community and select yours
Synthomer (LON:SYNT) First Half 2025 Results Key Financial Results
-
Revenue: UK£925.2m (down 9.8% from 1H 2024).
-
Net loss: UK£35.9m (loss widened by 20% from 1H 2024).
-
UK£0.22 loss per share (further deteriorated from UK£0.18 loss in 1H 2024).
LSE:SYNT Earnings and Revenue Growth August 8th 2025
All figures shown in the chart above are for the trailing 12 month (TTM) period
Synthomer Earnings Insights
Looking ahead, revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 15% decline forecast for the Chemicals industry in the United Kingdom.
Performance of the British Chemicals industry.
The company’s shares are down 21% from a week ago.
Risk Analysis
You should learn about the 2 warning signs we’ve spotted with Synthomer (including 1 which shouldn’t be ignored).
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.